BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6433250)

  • 1. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
    Goodman LA; Chang RJ
    Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.
    Bonneville JF; Poulignot D; Cattin F; Couturier M; Mollet E; Dietemann JL
    Radiology; 1982 May; 143(2):451-5. PubMed ID: 7071347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine-induced regression of a suprasellar extending prolactinoma during pregnancy.
    Bergh T; Nillius SJ; Enoksson P; Wide L
    J Endocrinol Invest; 1984 Apr; 7(2):133-6. PubMed ID: 6725868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine treatment of women with suspected pituitary prolactin-secreting microadenomas.
    Archer DF; Lattanzi DR; Moore EE; Harger JH; Herbert DL
    Am J Obstet Gynecol; 1982 Jul; 143(6):620-5. PubMed ID: 7201244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.
    Nillius SJ; Bergh T; Lundberg PO; Stahle J; Wide L
    Fertil Steril; 1978 Dec; 30(6):710-2. PubMed ID: 729834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bromocriptine for prolactin-secreting adenomas: analysis by CT scan.
    Niwa J; Sato O; Tanabe S
    Comput Radiol; 1983; 7(4):237-41. PubMed ID: 6641185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term medical therapy and follow-up of pediatric-adolescent patients with prolactin-secreting macroadenomas.
    Blackwell RE; Younger JB
    Fertil Steril; 1986 May; 45(5):713-6. PubMed ID: 3699173
    [No Abstract]   [Full Text] [Related]  

  • 8. Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.
    Verde G; Loli P; Berselli ME; Tagliaferri M; Dallabonzana D; Oppizzi G; Liuzzi A; Chiodini PG; Luccarelli G; Lodrini S
    J Endocrinol Invest; 1984 Feb; 7(1):51-4. PubMed ID: 6715796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine reduction of prolactinoma size.
    Corenblum B; Hanley DA
    Fertil Steril; 1981 Dec; 36(6):716-9. PubMed ID: 7308514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT follow-up of microprolactinomas during bromocriptine-induced pregnancy.
    Dietemann JL; Portha C; Cattin F; Mollet E; Bonneville JF
    Neuroradiology; 1983; 25(3):133-8. PubMed ID: 6888713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
    Bergström M; Muhr C; Lundberg PO; Bergström K; Gee AD; Fasth KJ; Långström B
    J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid regression through bromocriptine therapy of a suprasellar extending prolactinoma during pregnancy.
    Tan SL; Jacobs HS
    Int J Gynaecol Obstet; 1986 Jun; 24(3):209-15. PubMed ID: 2880760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment. Case report.
    Crosignani PG; Mattei A; Ferrari C; Giovanelli MA
    Br J Obstet Gynaecol; 1982 Feb; 89(2):169-70. PubMed ID: 7066250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
    Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size reduction of a prolactin secreting adenoma during long-term treatment with the dopamine agonist lisuride.
    Chiodini PG; Liuzzi A; Verde G; Cozzi R; Silvestrini F; Marsili MT; Horowski R; Passerini F; Luccarelli G; Borghi PG
    Clin Endocrinol (Oxf); 1980 Jan; 12(1):47-51. PubMed ID: 7379313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective management of a suprasellar extending prolactinoma during pregnancy.
    Pittini L; Minisci N; Negri P
    Clin Exp Obstet Gynecol; 1987; 14(3-4):152-4. PubMed ID: 3454722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of prolactinomas--1986.
    Tan SL; Jacobs HS
    Br J Obstet Gynaecol; 1986 Oct; 93(10):1025-9. PubMed ID: 3790461
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bromocriptine therapy of prolactinoma in pregnancy].
    Nehmzow M; Ventz M; Meng W
    Zentralbl Gynakol; 1985; 107(14):899-903. PubMed ID: 4036407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size reduction of extrasellar pituitary tumors during bromocriptine treatment.
    Wollesen F; Andersen T; Karle A
    Ann Intern Med; 1982 Mar; 96(3):281-6. PubMed ID: 7059088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.